Showing 11 - 20 of 24,381
This paper examines the impact of Direct-to-Consumer Advertising (DTCA) of cholesterol-reducing drugs (statins) on … show that there is a positive and significant effect of DTCA exposure on getting diagnosed, purchasing statins and … exercising regularly, but the effect of DTCA exposure largely goes away with the exception of exercise when we control more …
Persistent link: https://www.econbiz.de/10014049645
We examine how direct to consumer advertising (DCA) affects the delay between diagnosis and pharmacological treatment for patients suffering from a common chronic disease. The primary data for this study consist of patients diagnosed with osteoarthritis (N=18,235) taken from a geographically...
Persistent link: https://www.econbiz.de/10014062456
It is taken as given by many policy makers that Direct-to-Consumer Advertising of prescription drugs drives inappropriate patients to treatment. Alternatively, advertising may provide useful information that causes appropriate patients to seek treatment. I study this dynamic in the context of...
Persistent link: https://www.econbiz.de/10014033798
The effects of television advertising in the market for health insurance are of distinct interest to both firms and regulators. Regulators are concerned about firms potentially using ads to "cream skim," or attract an advantageous risk pool, as well as the potential for firms to use...
Persistent link: https://www.econbiz.de/10014034968
This paper examines the optimal content regulation of DTCA by comparing two forms of DTCA-product-specific and category …-specific-and identifies a key tradeoff which underlies this policy debate. Our analysis suggests that the optimal form of DTCA depends … crucially on the cost effectiveness of DTCA and the market-size distortion induced by DTCA. When the cost of advertisement is …
Persistent link: https://www.econbiz.de/10013329470
In the 1990s, competition among health insurance funds (‘sickness funds’) was introduced in Germany. As one means of competition, free choice of initial health funds and subsequent switching between them was made available to all insured. Since then, the number of funds has decreased...
Persistent link: https://www.econbiz.de/10008516757
The following is a model of psychological contracting with unmonitorable performance, implicit offers, and screening for non-performance by the announcement of the expectation of performance. It is motivated by the $250 billion prescription drug industry, which spends $19 billion per year on...
Persistent link: https://www.econbiz.de/10005109577
In the 1990s, competition among health insurance funds (‘sickness funds’) was introduced in Germany. As one means of competition, free choice of initial health funds and subsequent switching between them was made available to all insured. Since then, the number of funds has decreased...
Persistent link: https://www.econbiz.de/10009021874
A fundamental question in pharmaceutical marketing management is: How does the effectiveness of detailing change when additional information on drugs is revealed via patients' experiences during the product lifecycle? To address this question, we develop a model of detailing and prescribing...
Persistent link: https://www.econbiz.de/10005787016
Healthcare payers try to reduce costs by promoting the use of cheaper generic drugs. We show that there are strong interrelations in drug prescriptions between the inpatient and the outpatient sector using a large administrative dataset from Austria. Patients with prior hospital visits have a...
Persistent link: https://www.econbiz.de/10011628426